Search

everythinglearnresearchcommunity

for

Search:↓

Nobiletin-loaded vesicles effectively treat skin cancer by restoring normal miRNA and antioxidant levels.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Green-synthesized nanoparticles can effectively target cancer cells, reducing side effects and improving treatment.

Alopecia causes smaller hair follicles and affects growth-related structures.

Certain hair straighteners and dyes may increase ovarian cancer risk, especially in African American/Black women.

HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.

Plant-based ingredients in hair care are being replaced by synthetic alternatives.

Lecithin-encapsulated resveratrol nanoparticles could be a safe and effective anti-cancer treatment.

Age, gender, and hair loss affect scalp characteristics differently in young Caucasian adults.

Key genes can rewire networks, changing skin appendage types.

Targeting METTL1 may help slow papillary thyroid cancer growth and spread.

Imaging intestinal stem cells might help detect early signs of colorectal cancer.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Polyherbal hair oils effectively promote hair growth and scalp health.

Clear guidance and encouragement for in-person medical care are needed for hair and scalp disorders.

Ayurveda-based care may improve quality of life for breast cancer patients without serious side effects.

Six key genes can predict bladder cancer outcomes and may serve as prognostic biomarkers.

Demographic and lifestyle factors significantly influence scalp diseases.

New markers can detect tumors, aid drug delivery, and treat cancer effectively and safely.

Women's hair gets thinner and grayer as they age, with treatments available for hair loss and graying.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

The study found genetic differences related to hair development that may explain hair loss in a patient with Trichorhinophalangeal syndrome type I.

A wearable cap-like device using light therapy reduced scalp skin lesions by 71% and was painless.

Experts say proper treatment and sensitivity are important for women's facial skin issues like acne and unwanted hair.

People respond differently to hair loss treatment with PRP because of individual differences in growth factors from platelets.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

Certain immune cells are more common on the top of the head and might help predict or treat common hair loss.

Symptom interference negatively affects quality of life in women with ovarian cancer.